An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

ClinicalTrials.gov ID: NCT06401356

Public ClinicalTrials.gov record NCT06401356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 3:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multicenter, Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Study identification

NCT ID: NCT06401356
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Novartis Pharmaceuticals; Industry
Enrollment: 50 participants

Conditions and interventions

Conditions

Interventions

Pelabresib Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 12, 2024
Primary completion: Jun 1, 2027
Completion: Jun 29, 2027
Last update posted: Jun 10, 2026

2024 – 2027

United States locations

U.S. sites: 6
U.S. states: 5
U.S. cities: 5

Facility	City	State	ZIP	Site status
University of California LA	Los Angeles	California	90095	Recruiting
Mayo Clinic Jacksonville	Jacksonville	Florida	32224	Recruiting
Northwestern University	Chicago	Illinois	60611	Recruiting
Uni Of Michigan Health System	Ann Arbor	Michigan	48109	Recruiting
New York Presbyterian Hospital	New York	New York	10021	Recruiting
Mt Sinai Medical Center	New York	New York	10029-6574	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06401356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 10, 2026 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06401356 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →